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Background: HIV infection in children is a public health prob-
lem in ressource-constrained settings. Despite the support of
the international community, meeting the cost of treatment and
biological follow up remains a challenge in Cameroon and the
developing world as a whole. The aim of this study was to evaluate
the impact of antiretroviral therapy on the biological proﬁle of HIV
infected children followed up at the University Teaching Hospital
of Yaounde (UTHY) in Cameroon.
Methods&Materials:Wecarriedouta retrospective study from
May 2003 to December 2012 at the paediatric service of the UTHY.
116 ﬁles of HIV infected children were studied. Data on the socio
demographic characteristics, family history in relation to HIV, bio-
logical investigations and the treatment outcome were collected.
We compared the results of biological investigations performed
before and six months after the initiation of antiretroviral therapy.
Data analysiswas performedusing EPI info and SPSS statistical soft-
ware. The study was approved by the Cameroon ethics committee.
Results: The mean age was 54.02±46.34 months. The sex ratio
was 0.96 in favor of males. This cohort was characterized by a late
diagnosis (49.95±45months) aswell as a late initiationof antiretro-
viral therapy (8.52±14.17months). Patients consulted when the
clinical and immunologic state was well advanced (74.2% and
83.3% respectively). Only 36 out of 116 children (31%) were able
to meet the cost of biological investigations before and six months
after the initiation of therapy. We noticed a signiﬁcant increase in
the following biological parameters after six months of therapy:
blood glucose levels of 0.09 g/L (0.75-0.84; p= 0.007), percentage
of CD4 in children below 5 years of age of 4.62% (20.12-24.75;
p=0.022), absolute value of CD4 in children above 5 years of 294
cells/mm3 (151.18-445.18; p=0.011), CD4/CD8 ratio of 0.35 (0.55-
0.90; p=0.000). Interestingly, after six months of therapy, there
was a decrease in viral load of 3.90 log 10 copies/ml (5.85-1.95;
p=0.006).
Conclusion: This study demonstrated that immune restora-
tion and virologic suppression in children were obtained after six
months of therapy. Therefore, making biological follow up afford-
able to this vulnerable group is essential in our quest for a good
therapeutic outcome.
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Background: Neurological symptoms are common in HIV-
infected patients, with meningitis, stroke and seizures associated
with acute onset conditions and neurocognitive disorders (HAND)
common in late infection. Identifying a speciﬁc cause is difﬁ-
cult, with potential infectious aetiologies limited by the diagnostic
repertoire available in the routine microbiology and virology labo-
ratory. Next generation sequencing (NGS) is an unbiased approach
to search for novel and other neurotropic infectious agents.
A NGS pilot study was undertaken to identify the viruses in
cerebrospinal ﬂuid (CSF) of HIV-infected patients presenting with
a range of neurological symptoms.
Methods & Materials: Total nucleic acid was extracted from
the CSF of 15 HIV-infected patients with meningitis (n=4), HAND
(n=10) and young stroke (n=1). RNA was reverse transcribed and ss
cDNA/DNA converted to ds DNA. The Nextera sample preparation
kitwasused for indexingandpreparationof samples for sequencing
on the Illumina MiSeq platform. Human and bacterial sequences
were removed using DeconSeq and raw viral reads taxonomically
characterized using the web-based METAVIR server.
Results: Neurotropic viruses, HIV and HHV6, were detected in
2/4 meningitis and 2/10 HAND cases. Other viruses identiﬁed were
inﬂuenza virus A H1N1 (1 HAND case), ﬂavivirus GBV-C (1 stroke
and HAND case), TTV (1 stroke case) and human papillomavirus
(1 HAND case). In 5 samples parvoviruses were detected. Bacte-
riophages from a range of bacterial hosts including Streptococcus,
Pseudomonas, Enterobacteria, Lactobacillus and Staphylococcus,
made up a signiﬁcant proportion (up to 60%) of the viral sequences
detected in all samples.
Conclusion: The paucity of neurotropic viral sequences
detected in the CSF of this group of patients suggests that other fac-
tors were responsible for the neurological disease. The detection of
inﬂuenza virus and GBV-C is surprising, but there is evidence that
theymay invade theCNS. Bacteriophagesmakeup thevastmajority
of viruses found in the human virome from the gut and respira-
tory tract, but this is the ﬁrst report of their ubiquitous presence in
CSF. SequencingusingadifferentNGSplatformmayprovide further
evidence of viral infection in these patients.
http://dx.doi.org/10.1016/j.ijid.2014.03.685
